Rabies Immune Globulin (Human) Market Share, Sales Volume, Price Analysis Report 2025
Global Info Research released “Global Rabies Immune Globulin (Human) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031”. This report includes an overview of the development of the Rabies Immune Globulin (Human) industry chain, the market status of Rabies Immune Globulin (Human) Market, and key Players in developed and Rabies Immune Globulin (Human) market, and analyze the cutting-edge technology, patent, hot applications and market trends of Rabies Immune Globulin (Human) industry.
According to our (Global Info Research) latest study, the global Rabies Immune Globulin (Human) market size was valued at US$ 1663 million in 2024 and is forecast to a readjusted size of USD 2168 million by 2031 with a CAGR of 3.9% during review period.
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rabies Immune Globulin (Human) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rabies Immune Globulin (Human), with revenue, gross margin and global market share of Rabies Immune Globulin (Human) from 2020 to 2025.
Chapter 3, the Rabies Immune Globulin (Human) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the Rabies Immune Globulin (Human) market size by Type and application, with consumption value and growth rate by Type, application, from 2020 to 2031.
Chapter 6, 7, 8, 9, and 10, to break the Rabies Immune Globulin (Human) market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Rabies Immune Globulin (Human) market forecast, by regions, type and sales channel, with consumption value, from 2026 to 2031.
Chapter 11, Rabies Immune Globulin (Human) market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rabies Immune Globulin (Human).
Chapter 13, to describe Rabies Immune Globulin (Human) research findings and conclusion.
Sample Report Request Rabies Immune Globulin (Human) @:
https://www.globalinforesearch.com/reports/2626990/rabies-immune-globulin--human
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 HyperRAB S/D
1.3.3 KEDRAB
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Immune Globulin (Human) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Clinic
1.4.3 Hospital
1.5 Global Rabies Immune Globulin (Human) Market Size & Forecast
1.5.1 Global Rabies Immune Globulin (Human) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Rabies Immune Globulin (Human) Sales Quantity (2020-2031)
1.5.3 Global Rabies Immune Globulin (Human) Average Price (2020-2031)
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Rabies Immune Globulin (Human) Product and Services
2.1.4 CSL Behring Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Rabies Immune Globulin (Human) Product and Services
2.2.4 Grifols Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Rabies Immune Globulin (Human) Product and Services
2.3.4 Sanofi Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Sanofi Recent Developments/Updates
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Rabies Immune Globulin (Human) Product and Services
2.4.4 Kamada Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Kamada Recent Developments/Updates
2.5 Bharat Serum
2.5.1 Bharat Serum Details
2.5.2 Bharat Serum Major Business
2.5.3 Bharat Serum Rabies Immune Globulin (Human) Product and Services
2.5.4 Bharat Serum Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Bharat Serum Recent Developments/Updates
2.6 Bio Products Laboratory
2.6.1 Bio Products Laboratory Details
2.6.2 Bio Products Laboratory Major Business
2.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
2.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bio Products Laboratory Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
2.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Weiguang Bio
2.8.1 Weiguang Bio Details
2.8.2 Weiguang Bio Major Business
2.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product and Services
2.8.4 Weiguang Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Weiguang Bio Recent Developments/Updates
2.9 Shuanglin Bio
2.9.1 Shuanglin Bio Details
2.9.2 Shuanglin Bio Major Business
2.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
2.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Shuanglin Bio Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Rabies Immune Globulin (Human) Product and Services
2.10.4 CBPO Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments/Updates
2.11 CNBG
2.11.1 CNBG Details
2.11.2 CNBG Major Business
2.11.3 CNBG Rabies Immune Globulin (Human) Product and Services
2.11.4 CNBG Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 CNBG Recent Developments/Updates
2.12 Sichuan Yuanda Shuyang
2.12.1 Sichuan Yuanda Shuyang Details
2.12.2 Sichuan Yuanda Shuyang Major Business
2.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
2.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Sichuan Yuanda Shuyang Recent Developments/Updates
2.13 Kedrion Biopharma
2.13.1 Kedrion Biopharma Details
2.13.2 Kedrion Biopharma Major Business
2.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
2.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Kedrion Biopharma Recent Developments/Updates
2.14 Congruent Pharmachem
2.14.1 Congruent Pharmachem Details
2.14.2 Congruent Pharmachem Major Business
2.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
2.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Congruent Pharmachem Recent Developments/Updates
2.15 hualanbio
2.15.1 hualanbio Details
2.15.2 hualanbio Major Business
2.15.3 hualanbio Rabies Immune Globulin (Human) Product and Services
2.15.4 hualanbio Rabies Immune Globulin (Human) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 hualanbio Recent Developments/Updates
3 Competitive Environment: Rabies Immune Globulin (Human) by Manufacturer
3.1 Global Rabies Immune Globulin (Human) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Rabies Immune Globulin (Human) Revenue by Manufacturer (2020-2025)
3.3 Global Rabies Immune Globulin (Human) Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Rabies Immune Globulin (Human) Manufacturer Market Share in 2024
3.4.3 Top 6 Rabies Immune Globulin (Human) Manufacturer Market Share in 2024
3.5 Rabies Immune Globulin (Human) Market: Overall Company Footprint Analysis
3.5.1 Rabies Immune Globulin (Human) Market: Region Footprint
3.5.2 Rabies Immune Globulin (Human) Market: Company Product Type Footprint
3.5.3 Rabies Immune Globulin (Human) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rabies Immune Globulin (Human) Market Size by Region
4.1.1 Global Rabies Immune Globulin (Human) Sales Quantity by Region (2020-2031)
4.1.2 Global Rabies Immune Globulin (Human) Consumption Value by Region (2020-2031)
4.1.3 Global Rabies Immune Globulin (Human) Average Price by Region (2020-2031)
4.2 North America Rabies Immune Globulin (Human) Consumption Value (2020-2031)
4.3 Europe Rabies Immune Globulin (Human) Consumption Value (2020-2031)
4.4 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value (2020-2031)
4.5 South America Rabies Immune Globulin (Human) Consumption Value (2020-2031)
4.6 Middle East & Africa Rabies Immune Globulin (Human) Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
5.2 Global Rabies Immune Globulin (Human) Consumption Value by Type (2020-2031)
5.3 Global Rabies Immune Globulin (Human) Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
6.2 Global Rabies Immune Globulin (Human) Consumption Value by Application (2020-2031)
6.3 Global Rabies Immune Globulin (Human) Average Price by Application (2020-2031)
7 North America
7.1 North America Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
7.2 North America Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
7.3 North America Rabies Immune Globulin (Human) Market Size by Country
7.3.1 North America Rabies Immune Globulin (Human) Sales Quantity by Country (2020-2031)
7.3.2 North America Rabies Immune Globulin (Human) Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
8.2 Europe Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
8.3 Europe Rabies Immune Globulin (Human) Market Size by Country
8.3.1 Europe Rabies Immune Globulin (Human) Sales Quantity by Country (2020-2031)
8.3.2 Europe Rabies Immune Globulin (Human) Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Rabies Immune Globulin (Human) Market Size by Region
9.3.1 Asia-Pacific Rabies Immune Globulin (Human) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Rabies Immune Globulin (Human) Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
10.2 South America Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
10.3 South America Rabies Immune Globulin (Human) Market Size by Country
10.3.1 South America Rabies Immune Globulin (Human) Sales Quantity by Country (2020-2031)
10.3.2 South America Rabies Immune Globulin (Human) Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Rabies Immune Globulin (Human) Market Size by Country
11.3.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Rabies Immune Globulin (Human) Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Rabies Immune Globulin (Human) Market Drivers
12.2 Rabies Immune Globulin (Human) Market Restraints
12.3 Rabies Immune Globulin (Human) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Rabies Immune Globulin (Human) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Immune Globulin (Human)
13.3 Rabies Immune Globulin (Human) Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Immune Globulin (Human) Typical Distributors
14.3 Rabies Immune Globulin (Human) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Contact Us
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.